-
May 2014
FOXP3 and scurfy: how it all began.
Nat Rev ImmunolRamsdell F, Ziegler SF -
Apr 2014
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.
Diabetes CareSosenko JM, Skyler JS, Mahon J, Krischer JP, Greenbaum CJ, Rafkin LE, Beam CA, Boulware DC, Matheson D, Cuthbertson D, Herold KC, Eisenbarth G, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups. -
Apr 2014
Versican and the control of inflammation.
Matrix BiolWight TN, Kang I, Merrilees MJ -
Apr 2014
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.
Diabetes CareOrban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Peakman M, Raskin P, Russell WE, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group. -
Apr 2014
Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation.
ThoraxTill SJ, Raynsford EJ, Reynolds CJ, Quigley KJ, Grzybowska-Kowalczyk A, Saggar LR, Goldstone A, Maillère B, Kwok WW, Altmann DM, Durham SR, Boyton RJ -
Mar 2014
Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells
ImmunityRay JP, Marshall HD, Laidlaw BJ, Staron MM, Kaech SM, Craft J -
Mar 2014
Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells.
ImmunityVan Dyken SJ, Mohapatra A, Nussbaum JC, Molofsky AB, Thornton EE, Ziegler SF, McKenzie AN, Krummel MF, Liang HE, Locksley RM -
Mar 2014
A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma.
J Transl MedKhaenam P, Rinchai D, Altman MC, Chiche L, Buddhisa S, Kewcharoenwong C, Suwannasaen D, Mason M, Whalen E, Presnell S, Susaengrat W, O'Brien K, Nguyen QA, Gersuk V, Linsley PS, Lertmemongkolchai G, Chaussabel D, +Presnell SR -
Mar 2014
Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.
J Allergy Clin ImmunolWambre E, DeLong JH, James EA, Torres-Chinn N, Pfützner W, Möbs C, Durham SR, Till SJ, Robinson D, Kwok WW -
Mar 2014
MyD88 and IL-1: loosening T(reg) cells' firm grip.
Trends ImmunolCampbell DJ -
Mar 2014
Residual C-peptide in type 1 diabetes: what do we really know?
Pediatr DiabetesVanBuecken DE, Greenbaum CJ -
Feb 2014
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.
Database (Oxford)Zhong J, Sharma J, Raju R, Palapetta SM, Prasad TS, Huang TC, Yoda A, Tyner JW, van Bodegom D, Weinstock DM, Ziegler SF, Pandey A -
Feb 2014
B-lymphocyte depletion with rituximab and β-cell function: two-year results.
Diabetes CarePescovitz MD, Greenbaum CJ, Bundy B, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, Moran A, Raskin P, Rodriguez H, Schatz DA, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Anti-CD20 Study Group. -
Feb 2014
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease.
Matrix BiolChang MY, Tanino Y, Vidova V, Kinsella MG, Chan CK, Johnson PY, Wight TN, Frevert CW -
Feb 2014
Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.
Scand J ImmunolPieper J, Johansson S, Snir O, Linton L, Rieck M, Buckner JH, Winqvist O, van Vollenhoven R, Malmström V
